Cramer’s Got His Eye on Allergan, Himax, and These 3 Stocks

Jim Cramer made the following calls on August 1st, 2013. What do you think about his picks?

Allergan Inc. (NYSE:AGN): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on May 6, 2013. The stock’s 52-week high is $116.45, and its 52-week low is $81.33.

David Pyott, chairman and CEO of Allergan, came on Cramer last night to discuss the state of his business. After beating market expectations for earnings, Pyott noted that while a generic competitor for one of its eye medications looms, the FDA has got it tied up in reviews, meaning less competition for Allergan for the time being.

agn-20130802

Himax Technologies, Inc. (NASDAQ:HIMX): Jim Cramer ranked this stock a Buy. The stock’s 52-week high is $8.19, and its 52-week low is $1.51.

Himax got an endorsement to ‘Cramerica’ as another lightning round pick, and Cramer sounded confident talking to viewers, saying “I think it’s a buy. I’m not going against them. I’m thumbs up on this one.” The company recently signed a research agreement with Google (NASDAQ:GOOG) covering the cost of production upgrades for Himax. Earnings are due on the 15th.

himx-20130802

Acorda Therapeutics, Inc. (NASDAQ:ACOR): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on January 9, 2013. The stock’s 52-week high is $40.87, and its 52-week low is $21.33.

Cramer recommended the company on last night’s show as a more speculative pick, something which may be appropriate after yesterday’s conference call. While the company’s multiple sclerosis drug Ampyra continues to do well, Dr. Ron Cohen, who was also on Mad Money last night, said in the call that going forward, “Quarterly sales patterns are uneven, and we do not expect to see the same rate of quarter-over-quarter growth for the rest of the year.”

acor-20130802

Applied Materials Inc. (NASDAQ:AMAT): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on June 18, 2013. The stock’s 52-week high is $16.78, and its 52-week low is $9.95.

Applied Materials got the green light during the lightning round last night, when Cramer told viewers to avoid SunPower (NASDAQ:SPWR), saying that, “No. You don’t want to touch this one. I’d go with Applied Materials which owns a small sliver of that market.” Applied Materials is trading within 30 cents of its 52-week high, and is due for earnings to be released on August 15th.

amat-20130802

DexCom, Inc. (NASDAQ:DXCM): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on March 18, 2011. The stock’s 52-week high is $24.36, and its 52-week low is $11.36.

DexCom also got some lightning round love, when Cramer said that, “That’s a good situation, with a great chart, too.” Earnings for DexCom are out August 7th.

dxcm-20130802

Don’t Miss: Citigroup Is Slammed With $590 Million Ghost from the Financial Crisis.

More from The Cheat Sheet